HnRNP R Activators refer to a specific class of compounds that enhance the functional activity of hnRNP R, a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) family. These activators are recognized for their role in modulating the biochemical pathways that hnRNP R is involved in, particularly those related to RNA processing and metabolism. hnRNP R is known to bind to RNA substrates and is implicated in various aspects of mRNA biogenesis, including splicing, transport, and stability. The activators of hnRNP R play a crucial role in these processes by influencing the protein's interaction with RNA, thereby impacting post-transcriptional regulation. For instance, certain small molecule ligands might enhance hnRNP R's RNA-binding affinity, leading to a more efficient assembly of ribonucleoprotein complexes. This, in turn, can result in a more effective splicing and maturation of pre-mRNA into functional mRNA. Additionally, these activators may also function by modulating the phosphorylation state of hnRNP R, which is known to affect its localization and interaction with other proteins and RNA sequences. Through such precise molecular mechanisms, hnRNP R activators can exert a profound effect on gene expression regulation at the post-transcriptional level.
The specificity of hnRNP R activators is reflected in their ability to target discrete signaling pathways that intersect with the functional dynamics of hnRNP R. By enhancing the protein's activity, these compounds indirectly influence the expression patterns of genes that hnRNP R regulates. For example, an activator might enhance the export of mature mRNA from the nucleus by promoting the association of hnRNP R with export receptors, thus facilitating a key step in gene expression. Alternatively, certain activators may bolster hnRNP R's involvement in mRNA turnover and degradation pathways, ensuring the appropriate modulation of gene expression responsive to cellular needs. The precise molecular interactions between hnRNP R activators and their targets are crucial for the fine-tuning of RNA-related processes, and they achieve this without necessitating changes in hnRNP R's expression levels. By stabilizing the formation of mRNA-protein complexes or influencing the localization and mobility of hnRNP R within the cell, these activators contribute to the intricate regulatory network that controls cellular homeostasis and the response to physiological stimuli.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly increases cellular cAMP levels, which in turn activates PKA (Protein Kinase A). PKA can phosphorylate various substrates, including those that can interact with hnRNP R, thereby enhancing its RNA-binding and modulation activities. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
8-Bromoadenosine 3',5'-cyclic monophosphate acts as a cAMP analogue and activates PKA. Activated PKA can phosphorylate proteins that associate with hnRNP R, potentially increasing its activity related to mRNA metabolism. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), leading to elevated cAMP levels and subsequent activation of PKA. PKA can enhance hnRNP R activity by phosphorylation of associated regulatory proteins. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium, which can activate pathways involving calcium-dependent protein kinases. These kinases could modify the interaction of hnRNP R with its RNA targets, thereby enhancing its functional activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium concentration, activating calcium-dependent kinases that may phosphorylate substrates involved in the regulation of hnRNP R activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can phosphorylate serine and threonine residues on proteins that interact with hnRNP R, potentially enhancing its RNA processing functions. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG is a kinase inhibitor with a broad range of targets and could decrease competitive phosphorylation on proteins that associate with hnRNP R, leading to an indirect enhancement of hnRNP R activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter downstream AKT signaling. Inhibition of AKT may reduce phosphorylation of substrates that compete with hnRNP R for binding, thereby enhancing hnRNP R's RNA-binding capacity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is another PI3K inhibitor that, like LY294002, modulates AKT activity and could enhance hnRNP R's activity by reducing competitive interactions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAPK, which might affect proteins that regulate hnRNP R's function. By inhibiting p38 MAPK, SB203580 could shift cellular signaling to enhance hnRNP R's role in RNA metabolism. |